Moleculin Biotech Inc (NASDAQ: MBRX) started the day on Thursday, with a price decrease of -5.80% at $0.45, before settling in for the price of $0.48 at the close. Taking a more long-term approach, MBRX posted a 52-week range of $0.25-$3.65.
The Healthcare sector firm’s twelve-monthly sales growth has been 26.36% for the last half of the decade. Meanwhile, its Annual Earning per share during the time was 26.36%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 80.33%. This publicly-traded company’s shares outstanding now amounts to $49.50 million, simultaneously with a float of $45.11 million. The organization now has a market capitalization sitting at $22.36 million. At the time of writing, stock’s 50-day Moving Average stood at $0.4602, while the 200-day Moving Average is $0.8136.
Moleculin Biotech Inc (MBRX) Ownership Facts and Figures
Now let’s turn our focus to how large-scale investors are working with this stock of the Biotechnology Industry. Moleculin Biotech Inc’s current insider ownership accounts for 8.87%, in contrast to 0.89% institutional ownership. According to the most recent insider trade that took place on Jun 23 ’25, this organization’s Chief Financial Officer bought 270,270 shares at the rate of 0.37, making the entire transaction reach 100,000 in total value, affecting insider ownership by 287,587. Preceding that transaction, on Jun 23 ’25, Company’s CEO and President bought 675,675 for 0.37, making the whole transaction’s value amount to 250,000. This particular insider is now the holder of 743,607 in total.
Moleculin Biotech Inc (MBRX) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.26 per share during the current fiscal year.
Moleculin Biotech Inc’s EPS increase for this current 12-month fiscal period is 80.33% and is forecasted to reach -1.05 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 45.64% through the next 5 years, which can be compared against the 26.36% growth it accomplished over the previous five years trading on the market.
Moleculin Biotech Inc (NASDAQ: MBRX) Trading Performance Indicators
Let’s observe the current performance indicators for Moleculin Biotech Inc (MBRX). It’s Quick Ratio in the last reported quarter now stands at 1.15.
In the same vein, MBRX’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -4.59, a figure that is expected to reach -0.26 in the next quarter, and analysts are predicting that it will be -1.05 at the market close of one year from today.
Technical Analysis of Moleculin Biotech Inc (MBRX)
If we take a close look at the recent performances of Moleculin Biotech Inc (NASDAQ: MBRX), its last 5-days Average volume was 10.01 million that shows progress from its year to date volume of 4.39 million. During the previous 9 days, stock’s Stochastic %D was recorded 37.02% While, its Average True Range was 40.73.
Raw Stochastic average of Moleculin Biotech Inc (MBRX) in the period of the previous 100 days is set at 28.42%, which indicates a major rise in contrast to 18.23% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 0.0434 that was lower than 0.0594 volatility it exhibited in the past 100-days period.
